Novavax currently has a negative P/E (TTM) ratio of -3.13, indicating that it is currently unprofitable. It is important to note that a negative P/E ratio is not uncommon for companies that are in the process of transitioning from being unprofitable to profitable. However, it is important to conduct further analysis and research before making any investment decisions.